Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling

被引:583
作者
Goumans, MJ
Valdimarsdottir, G
Itoh, S
Lebrin, F
Larsson, J
Mummery, C
Karlsson, S
ten Dijke, P
机构
[1] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands
[2] Univ Lund Hosp, Mol Med & Gene Therapy Inst Lab Med, S-22184 Lund, Sweden
[3] Univ Lund Hosp, Dept Med, S-22184 Lund, Sweden
[4] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands
关键词
D O I
10.1016/S1097-2765(03)00386-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta (TGFbeta) regulates the activation state of the endothelium via two opposing type I receptor/Smad pathways. Activin receptor-like kinase-1 (ALK1) induces Smad1/5 phosphorylation, leading to an increase in endothelial cell proliferation and migration, while ALK5 promotes Smad2/3 activation and inhibits both processes. Here, we report that ALK5 is important for TGFbeta/ALK1 signaling; endothelial cells lacking ALK5 are deficient in TGFbeta/ALK1-induced responses. More specifically, we show that ALK5 mediates a TGFbeta-dependent recruitment of ALK1 into a TGFbeta receptor complex and that the ALK5 kinase activity is required for optimal ALK1 activation. TGFbeta type II receptor is also required for ALK1 activation by TGFbeta. Interestingly, ALK1 not only induces a biological response opposite to that of ALK5 but also directly antagonizes ALK5/Smad signaling.
引用
收藏
页码:817 / 828
页数:12
相关论文
共 35 条
  • [1] IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS
    ATTISANO, L
    CARCAMO, J
    VENTURA, F
    WEIS, FMB
    MASSAGUE, J
    WRANA, JL
    [J]. CELL, 1993, 75 (04) : 671 - 680
  • [2] A system for stable expression of short interfering RNAs in mammalian cells
    Brummelkamp, TR
    Bernards, R
    Agami, R
    [J]. SCIENCE, 2002, 296 (5567) : 550 - 553
  • [3] Candia AF, 1997, DEVELOPMENT, V124, P4467
  • [4] TYPE-I RECEPTORS SPECIFY GROWTH-INHIBITORY AND TRANSCRIPTIONAL RESPONSES TO TRANSFORMING GROWTH-FACTOR-BETA AND ACTIVIN
    CARCAMO, J
    WEIS, FMB
    VENTURA, F
    WIESER, R
    WRANA, JL
    ATTISANO, L
    MASSAGUE, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) : 3810 - 3821
  • [5] Oxidation of NO mediated by water-soluble iron porphyrin
    Chen, JY
    Ikeda, O
    Hatasa, T
    Kitajima, A
    Miyake, M
    Yamatodani, A
    [J]. ELECTROCHEMISTRY COMMUNICATIONS, 1999, 1 (07) : 274 - 277
  • [6] Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
    Dennler, S
    Itoh, S
    Vivien, D
    ten Dijke, P
    Huet, S
    Gauthier, JM
    [J]. EMBO JOURNAL, 1998, 17 (11) : 3091 - 3100
  • [7] CLONING OF A TYPE-I TGF-BETA RECEPTOR AND ITS EFFECT OF TGF-BETA BINDING TO THE TYPE-II RECEPTOR
    EBNER, R
    CHEN, RH
    SHUM, L
    LAWLER, S
    ZIONCHECK, TF
    LEE, A
    LOPEZ, AR
    DERYNCK, R
    [J]. SCIENCE, 1993, 260 (5112) : 1344 - 1348
  • [8] Balancing the activation state of the endothelium via two distinct TGF-β type I receptors
    Goumans, MJ
    Valdimarsdottir, G
    Itoh, S
    Rosendahl, A
    Sideras, P
    ten Dijke, P
    [J]. EMBO JOURNAL, 2002, 21 (07) : 1743 - 1753
  • [9] Goumans MJ, 2000, INT J DEV BIOL, V44, P253
  • [10] A simplified system for generating recombinant adenoviruses
    He, TC
    Zhou, SB
    da Costa, LT
    Yu, J
    Kinzler, KW
    Vogelstein, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) : 2509 - 2514